Aurobindo Pharma Ltd

Plot No.# 2

Maitri Vihar, Ameerpet

500038 Hyderabad , India

To be linked to this company

Activity

Manufacturers and Exporters of some of the most quality conscious Active Pharmaceutical Ingredients (bulk actives), intermediates, Peptides and speciality generic formulations.
Manufactures of semi synthetic penicillins and cephalosporins.
Manufacturer of Bulk Drugs, Intermediates & Formulations such as Antibiotic Penicillins, Antibiotic Cephalosporins, Anti - Microbials, Anti - Microbials - Quinolones, Macrolides, Sunfonamides, Antiprotozoals, Cardiovasculars, Anti Ashthmatics, Anti Fungals, Sterile - Parenterals, Fluroquinolo
Product Profile:
ANTI-DEPRESSANTS: Citalopram HBr, Bupropion HCl, Fluoxetine HCl,Gabapentin, Melitracin HCl, Mirtazapine, Paroxetine HCl, Risperidone, Sertraline HCl.
ANTI-CONVULSANTS- Leviteracetam,Topiramate.
HYPNOTICS & ANTI-PSYCHOTICS-Flupenthixol,Olanzapine,Zolpidem,Quetiapine,Zaleplon.
ANTI-HYPERTENSIVES-Benazepril, Fosinopril, Lisinopril, Perindopril, Quinapril, Ramipril, Trandolapril, Losartan Potassium.
BETA BLOCKERS- Bisoprolol Fumarate, Carvedilol.
THIAZIDE DIURETIC- Hydrochlorothiazide.
ANTI-THROMBOTIC - Clopidogrel bisulfate, Pentoxifylline.
STATINS- Atorvastatin Calcium, Fluvastatin, Simvastatin.
ANTI-DIABETICS- Gilbenclamide, Metformin HCL.
BPH-TREATMENT- Finasteride, Tamsulosin.
ANTI-EMETICS - Domperidone Base/Maleate, Ondansetron HCL.
ANTI-ULCERANTS - Lansoprazole Powder/Pellets, Omeprazole Powder/Pellets, Pantoprazole Sodium, Rabeprazole Sodium.
ANTI-RETROVIRALS- Abacavir, Didanosine, Efavirenz, Indinavir, Lamivudine, Lopinavir, Nelfinavir, Mesylate, Nevirapine, Ritonavir,
Saquinavir, Stavudine , Zidovudine .
ANTI-VIRALS - Ribavirin.
MACROLIDES- Azithromycin Monohydrate.
ANTI-FUNGALS - Fluconazole, Terbinafine HCl.
QUINOLONES- Ciprofloxacin HCL, Moxifloxacin
ANTI-HISTAMINES - Fexofenadine
ANTI-CHOLINERGI-Tolterodine
ANTI-OSTEOPOROSIS -Alendronate Sodium
ANTI-INFLAMMATORY-Meloxicam
MUSCLE RELAXANT - Carisprodol
CEPHALOSPORINS, ANTI-INFECTIVES,

General Information

Year Established: 1986

www : http://www.aurobindo.com

Type of company : Headquarters

Certifications

Type:ISO 9001

Brand/Tradenames

  • AUROBINDO

Catalogues

Video

Import/export regions

Import regions :
Export regions :
  • Worldwide
  • Asia-Pacific
  • South America
  • Central/East Europe
  • Africa
  • North America
  • Western Europe

Employees

On site
Unknown
Company
More than 5000
Total group
Unknown

Turnover

2012 : 46,520,000,000 INR

Activities

P = Producer / D = Distributor / S = Service

Products

This company has not added any products

Executives

K. Ragunathan

Independent Director & Non-Executive Chairman

K. R.

Wholetime Director & Vice Chairman

P. R.

Non-Executive Director

N. G.

MD

M. R.

Whole Time Director

M. K.

Wholetime Director

M. M.

Independent Director

D. R.

Independent Director

C. R.

Independent Director

P. R.

Non-Executive Director

A. R.

General Manager (Legal)

S. S.

Chief Finance Officer

P. S.

Purchase Head

News

Aurobindo Pharma acquires Actavis operations in 7 European countries

Aurobindo Pharma acquires Actavis operations in 7 European countries

Published on Wednesday, 2 April, 2014 9:14 AM

Hyderabad: Aurobindo Pharma Ltd has completed the acquisition of certain commercial operations in Western Europe from Actavis Plc. In January this year, the Hyderabad-based Aurobindo Pharma had signed an agreement with Actavis to acquire its personnel, commercial infrastructure, products, marketing authorisations and dossier licence rights in seven European countries for €30 million.

Both companies had also inked a long-term commercial and supply arrangement.

“The acquisition will make Aurobindo one of the leading Indian pharmaceutical companies in Europe with a top 10 position in several key markets,’’ Muralidharan, Senior Vice-President of European operations for Aurobindo, said here on Tuesday.

Smooth transition

Aurobindo would work to combine the strength of both enterprises in these markets and to identify and maximise all opportunities.

“We will continue to collaborate with Actavis to ensure business continuity and a smooth transition. In parallel, we will work closely with the acquired management teams to achieve a rapid and successful integration,’’ he added. Aurobindo’s scrip gained 4.67 per cent on BSE on Tuesday to end at Rs. 534.70.

Disclaimer: Orignal source from IBEF http://ibef.org/news/aurobindo-pharma-acquires-actavis-operations-in-7-european-countries